Abstract

The vaccine market is one of the most attractive and fast-growing segments of the global pharmaceutical market. The increasing interest in the development and creation of new vaccines caused a significant influx of investment in research activities, which did not slow down the impact on the further development of the market. The present research featured the global market for COVID-19 vaccines. The research objective was to assess the state of the COVID vaccine market as a new segment of the global vaccine market. The work uses statistical materials of the World Health Organization, the International Federation of Pharmaceutical Manufacturers and Associations, Statista, Rosstat, and Rospotrebnadzor, as well as methods of general logical, analytical, statistical, and empirical analyses. The demands for the global COVID-19 vaccine market are currently enormous, and the global demand for COVID-19 vaccines can range from 10 to 14 billion doses per year, depending on the desired level of coverage and the need for re-vaccination. The current leading manufacturers of vaccines against COVID-19 are Pfizer (USA) / BioNTech (Germany), Sinovac Biotech (China), AstraZeneca (UK), Moderna (USA), and Sinopharm (China). In terms of production volumes, they are significantly inferior to N. F. Gamaleya Federal Research Center for Epidemiology and Microbiology (Russia). The prevalence of World Health Organization-approved vaccines differs by country: (1) Vaxzevria vaccine (AstraZeneca) was approved in 101 countries, (2) Pfizer / BioNTech – in 85 countries, (3) Moderna – in 46 countries, (4) Sinopharm vaccines – 42 countries, (5) Janssen (Johnson & Johnson) – in 41 countries, (6) Covishield (Serum Institute of India) – in 40 countries. As of May 20, 2021, the Russian Sputnik V was registered in 68 countries. For all manufacturers, the expansion of production provokes the same problems, which are mostly connected with the supply of culture media, filters, disposable consumables, and equipment, especially during peak demand.

Highlights

  • When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil // Vaccine. 2021

  • The increasing interest in the development and creation of new vaccines caused a significant influx of investment in research activities, which did not slow down the impact on the further development of the market

  • The present research featured the global market for COVID-19 vaccines

Read more

Summary

Introduction

В. О современных тенденциях развития мирового и российского рынка вакцин // Современные научные исследования и инновации. В. Обзор российского рынка вакцин: специфика, динамика развития, перспективы // Современная организация лекарственного обеспечения. Current progress and challenges in the design and development of a successful COVID-19 vaccine // Fundamental Research. The find of COVID-19 vaccine: challenges and opportunities // Journal of Infection and Public Health.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call